Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells
Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells
Enrolling by invitation · NCT03628612 · Registry updated 2026-09-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, T-cell non-Hodgkin lymphoma, cardiovascular disorder, diffuse large B-cell lymphoma, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Enrolling by invitation | Phase 2 | 2026-09-22 | NCT03628612 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Autolus Limited | 7 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust | Newcastle upon Tyne | United Kingdom | 1 |
| Hospital Vall d'Hebron | Barcelona | Spain | 3 |
| Manchester Royal Infirmary Hospital | Manchester | United Kingdom | 1 |
| Queen Elizabeth University Hospital | Glasgow | United Kingdom | 15 |
| Royal Manchester Children's Hospital | Manchester | United Kingdom | 12 |
| St David'S South Austin Medical Center | Austin | United States | 2 |
| University College London Hospitals NHS Foundation Trust | London | United Kingdom | 16 |
| University of Miami | Miami | United States | 327 |
| Washington University in St. Louis | St Louis | United States | 79 |